Cell Impact AB (publ) Share Price Nasdaq Stockholm
Equities
CI
SE0005003217
Industrial Machinery & Equipment
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.13 SEK | +4.00% | -12.04% | -42.22% |
26/04 | Cell Impact AB Signs Agreement Valued At SEK 3.2 Million | CI |
25/04 | Cell Impact AB Announces Board and Committee Changes | CI |
Sales 2022 | 91.53M 8.37M 698M | Sales 2023 | 47.66M 4.36M 363M | Capitalization | 133M 12.16M 1.01B |
---|---|---|---|---|---|
Net income 2022 | -104M -9.51M -793M | Net income 2023 | -121M -11.06M -922M | EV / Sales 2022 | 7.76 x |
Net cash position 2022 | 120M 10.97M 914M | Net cash position 2023 | 57.14M 5.22M 436M | EV / Sales 2023 | 1.59 x |
P/E ratio 2022 |
-7.96
x | P/E ratio 2023 |
-0.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.94% |
1 week | -11.44% | ||
Current month | -23.35% | ||
1 month | -20.34% | ||
3 months | -23.08% | ||
6 months | -78.76% | ||
Current year | -42.22% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vallin
CEO | Chief Executive Officer | 47 | 01/21/01 |
Human Resources Officer | 52 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 01/22/01 | |
Director/Board Member | 73 | 11/17/11 | |
Robert Sobocki
CHM | Chairman | 72 | 01/20/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.75% | 20 M€ | -15.08% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.13 | +4.00% | 6,365,650 |
25/24/25 | 0.125 | -6.72% | 5,378,253 |
24/24/24 | 0.134 | +3.88% | 3,818,133 |
23/24/23 | 0.129 | -1.23% | 5,447,125 |
22/24/22 | 0.1306 | -11.04% | 9,100,652 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:59 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+54.30% | 3.74B | |
+8.22% | 2.04B | |
+0.43% | 1.99B | |
-6.79% | 1.91B | |
-5.37% | 1.38B | |
+15.70% | 1.36B | |
-16.05% | 1.38B | |
-28.65% | 1.3B | |
-17.02% | 1.24B |
- Stock Market
- Equities
- CI Stock
- CI Stock